Summary:
This study is evaluating the effects of an oral investigational medication on the progression of athersclerosis as well as the lipid profile.
Qualified Participants Must:
• Be 18-70 years of age
•
Have documented cholesterol >350 or
•
Have documented untreat LDL >200 or
•
Have documented treated LDL >130
•
Participants must also:
Have documented Xanthoma or
•
Have a relative who died prematurely due to CAD before age 65 or
•
Have documented nntreated cholesterol >350 and/or LDL >190 in 1st degree relative or
•
Have documented treated cholesterol
>280 and/or LDL >160 in 1st degree relative
•
Qualified Participants May Receive:
Study Medication, Physical Exams, Lab Tests, EKG,Nutritional Counsling, Carotid Scans. Participants will also be compensated up $425 for study completion;